CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status

Journal of Experimental Medicine

Volumn 200, Issue 3, 2004, Pages 331-343

  Kinter, Audrey L ^a   Hennessey, Margaret ^a   Bell, Alicia ^a   Kern, Sarah ^a   Lin, Yin ^a   Daucher, Marybeth ^a   Planta, Maria ^b   McGlaughlin, Mary ^a   Jackson, Robert ^a   Ziegler, Steven F ^c   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Cytokine; FoxP3; Human; Proliferation; Suppression

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VIRUS DNA;

ARTICLE; BLOOD; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MEMORY CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; WESTERN BLOTTING;

ANTIGENS, CD4; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; HIV; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 3543098686     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20032069     Document Type: Article

References (78)

1. Antonen, J., A. Ranki, S.L. Valle, E. Seppala, H. Vapaatalo, J. Suni, and K. Krohn. 1987. The validity of immunological studies in human immunodeficiency virus infection: a three-year follow-up of 235 homo- or bisexual persons. Acta Pathol. Microbiol. Immunol. Scand. [C]. 95:275-282.
2. Clerici, M., N.I. Stocks, R.A. Zajac, R.N. Boswell, D.R. Lucey, C.S. Via, and G.M. Shearer. 1989. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging. J. Clin. Invest. 84:1892-1899.
3. Miedema, F. 1992. Immunological abnormalities in the natural history of HIV infection: mechanisms and clinical relevance. Immunodefic. Rev. 3:173-193.
4. Pontesilli, O., M. Carlesimo, A.R. Varani, R. Ferrara, E.C. Guerra, M.L. Bernardi, G. Ricci, A.M. Mazzone, G. D'Offizi, and F. Aiuti. 1995. HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. Clin. Exp. Immunol. 100:419-424.
5. Dalod, M., M. Dupuis, J.C. Deschemin, C. Goujard, C. Deveau, L. Meyer, N. Ngo, C. Rouzioux, J.G. Guillet, J.F. Delfraissy, et al. 1999. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J. Clin. Invest. 104: 1431-1439.
6. Norris, P.J., and E.S. Rosenberg. 2001. Cellular immune response to human immunodeficiency virus. AIDS. 15:S16-S21.
7. Douek, D.C., J.M. Brenchley, M.R. Betts, D.R. Ambrozak, B.J. Hill, Y. Okamoto, J.P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, et al. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 417:95-98.
8. Champagne, P., G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:106-111.
9. Popik, W., and P.M. Pitha. 2000. Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry. Virology. 276:1-6.
10. Appay, V., and S.L. Rowland-Jones. 2002. Premature ageing of the immune system: the cause of AIDS? Trends Immunol. 23:580-585.
11. Lieberman, J., P. Shankar, N. Manjunath, and J. Andersson. 2001. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood. 98:1667-1677.
12. Lawn, S.D., S.T. Butera, and T.M. Folks. 2001. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 14:753-777.
13. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151-1164.
14. Suri-Payer, E., A.Z. Amar, A.M. Thornton, and E.M. Shevach. 1998. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212-1218.
15. Shevach, E.M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400.
16. Sakaguchi, S. 2003. Regulatory T cells: mediating compromises between host and parasite. Nat. Immunol. 4:10-11.
17. Mills, K.H., and P. McGuirk. 2004. Antigen-specific regulatory T cells-their induction and role in infection. Semin. Immunol. 16:107-117.
18. Powrie, F., and K.J. Maloy. 2003. Immunology. Regulating the regulators. Science. 299:1030-1031.
19. Shimizu, J., S. Yamazaki, and S. Sakaguchi. 1999. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 163:5211-5218.
20. Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59:3128-3133.
21. Kingsley, C.I., M. Karim, A.R. Bushell, and K.J. Wood. 2002. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168:1080-1086.
22. Sanchez-Fueyo, A., M. Weber, C. Domenig, T.B. Strom, and X.X. Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168:2274-2281.
23. Belkaid, Y., C.A. Piccirillo, S. Mendez, E.M. Shevach, and D.L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 420:502-507.
24. Hisaeda, H., Y. Maekawa, D. Iwakawa, H. Okada, K. Himeno, K. Kishihara, S. Tsukumo, and K. Yasutomo. 2004. Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells. Nat. Med. 10:29-30.
25. Long, T.T., S. Nakazawa, S. Onizuka, M.C. Huaman, and H. Kanbara. 2003. Influence of CD4+CD25+ T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33:175-183.
26. + T cell responses. J. Exp. Med. 196:1585-1592.
27. Hori, S., T.L. Carvalho, and J. Demengeot. 2002. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32: 1282-1291.
28. Montagnoli, C., A. Bacci, S. Bozza, R. Gaziano, P. Mosci, A.H. Sharpe, and L. Romani. 2002. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169:6298-6308.
29. Netea, M.G., R. Sutmuller, C. Hermann, C.A. Van der Graaf, J.W. Van der Meer, J.H. van Krieken, T. Hartung, G. Adema, and B.J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172:3712-3718.
30. Iwashiro, M., R.J. Messer, K.E. Peterson, I.M. Stromnes, T. Sugie, and K.J. Hasenkrug. 2001. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA. 98:9226-9230.
31. Dittmer, U., H. He, R.J. Messer, S. Schimmer, A.R. Olbrich, C. Ohlen, P.D. Greenberg, I.M. Stromnes, M. Iwashiro, S. Sakaguchi, et al. 2004. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity. 20:293-303.
32. + T cell responses. J. Exp. Med. 198:889-901.
33. Baecher-Allan, C., V. Viglietta, and D.A. Hafler. 2004. Human CD4+CD25+ regulatory T cells. Semin. Immunol. 16: 89-98.
34. Migueles, S.A., A.C. Laborico, W.L. Shupert, M.S. Sabbaghian, R. Rabin, C.W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, et al. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
35. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335-1346.
36. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2003. CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found Symp. 252:67-88.
37. Bruder, D., M. Probst-Kepper, A.M. Westendorf, R. Geffers, S. Beissert, K. Loser, H. von Boehmer, J. Buer, and W. Hansen. 2004. Neuropilin-1: a surface marker of regulatory T cells. Eur. J. Immunol. 34:623-630.
38. Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol. 4:330-336.
39. O'Garra, A., and P. Vieira. 2003. Twenty-first century Foxp3. Nat. Immunol. 4:304-306.
40. Khattri, R., T. Cox, S.A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4:337-342.
41. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061.
42. Walker, M.R., D.J. Kasprowicz, V.H. Gersuk, A. Benard, M.V. Landeghen, J.H. Buckner, and S.F. Zeigler. 2003. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112: 1437-1443.
43. Wing, K., A. Ekmark, H. Karlsson, A. Rudin, and E. Suri-Payer. 2002. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology. 106:190-199.
44. Cao, D., V. Malmstrom, C. Baecher-Allan, D. Hafler, L. Klareskog, and C. Trollmo. 2003. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur. J. Immunol. 33:215-223.
45. Baecher-Allan, C., J.A. Brown, G.J. Freeman, and D.A. Hafler. 2001. CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:1245-1253.
46. + T cells with regulatory properties from human blood. J. Exp. Med. 193:1303-1310.
47. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193:1295-1302.
48. Lehmann, J., J. Huehn, M. de la Rosa, F. Maszyna, U. Kretschmer, V. Krenn, M. Brunner, A. Scheffold, and A. Hamann. 2002. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA. 99:13031-13036.
49. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193:1285-1294.
50. Stassen, M., E. Schmitt, and H. Jonuleit. 2004. Human CD(4+)CD(25+) regulatory T cells and infectious tolerance. Transplantation. 77:S23-S25.
51. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor β1 production and responsiveness. J. Exp. Med. 196:237-246.
52. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194:629-644.
53. Levings, M.K., R. Bacchetta, U. Schulz, and M.G. Roncarolo. 2002. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int. Arch. Allergy Immunol. 129:263-276.
54. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
55. Piccirillo, C.A., and E.M. Shevach. 2001. Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J. Immunol. 167:1137-1140.
56. Aandahl, E.M., J. Michaelsson, W.J. Moretto, F.M. Hecht, and D.F. Nixon. 2004. Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78:2454-2459.
57. Taams, L.S., M. Vukmanovic-Stejic, J. Smith, P.J. Dunne, J.M. Fletcher, F.J. Plunkett, S.B. Ebeling, G. Lombardi, M.H. Rustin, J.W. Bijlsma, et al. 2002. Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur. J. Immunol. 32:1621-1630.
58. Cicala, C., J. Arthos, S.M. Selig, G. Dennis, Jr., D.A. Hosack, D. Van Ryk, M.L. Spangler, T.D. Steenbeke, P. Khazanie, N. Gupta, et al. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA. 99:9380-9385.
59. Maddon, P.J., A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:333-348.
60. Arthos, J., C. Cicala, S.M. Selig, A.A. White, H.M. Ravindranath, D. Van Ryk, T.D. Steenbeke, E. Machado, P. Khazanie, M.S. Hanback, et al. 2002. The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. Virology. 292:98-106.
61. Siliciano, R.F. 1996. The role of CD4 in HIV envelope-mediated pathogenesis. Curr. Top. Microbiol. Immunol. 205:159-179.
62. Fahey, J.L., J.M. Taylor, R. Detels, B. Hofmann, R. Melmed, P. Nishanian, and J.V. Giorgi. 1990. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Engl. J. Med. 322: 166-172.
63. + regulatory T cells in vivo. J. Exp. Med. 198:249-258.
64. Vahlenkamp, T.W., M.B. Tompkins, and W.A. Tompkins. 2004. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4(+)CD25(+) T regulatory cells. J. Immunol. 172:4752-4761.
65. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198:235-247.
66. Sugimoto, K., F. Ikeda, J. Stadanlick, F.A. Nunes, H.J. Alter, and K.M. Chang. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology. 38:1437-1448.
67. Iyasere, C., J.C. Tilton, A.J. Johnson, S. Younes, B. Yassine-Diab, R.P. Sekaly, W.W. Kwok, S.A. Migueles, A.C. Laborico, W.L. Shupert, et al. 2003. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77:10900-10909.
68. + T cells endowed with proliferative capacity. J. Exp. Med. 198:1909-1922.
69. Nelson, B.H. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172:3983-3988.
70. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036.
71. Yang, Y., C.T. Huang, X. Huang, and D.M. Pardoll. 2004. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol. 5:508-515.
72. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197:403-411.
73. + regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J. Exp. Med. 198:259-266.
74. Pantaleo, G., C. Graziosi, L. Butini, P.A. Pizzo, S.M. Schnittman, D.P. Kotler, and A.S. Fauci. 1991. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 88:9838-9842.
75. Xu, D., H. Liu, M. Komai-Koma, C. Campbell, C. McSharry, J. Alexander, and F.Y. Liew. 2003. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170:394-399.
76. Suvas, S., A.K. Azkur, B.S. Kim, U. Kumaraguru, and B.T. Rouse. 2004. CD4(+)CD25(+) regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172:4123-4132.
77. Deeks, S.G., and B.D. Walker. 2004. The immune response to AIDS virus infection: good, bad, or both? J. Clin. Invest. 113:808-810.
78. Leng, Q., G. Borkow, and Z. Bentwich. 2002. Attenuated signaling associated with immune activation in HIV-1-infected individuals. Biochem. Biophys. Res. Commun. 298:464-467.